newsfilter
← Latest News
GlobeNewswire·

Tempest Therapeutics Announces Up To $6 Million Private Placement

BRISBANE, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) (the "Company"), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product